| |
| |
|
| Insider
Information: |
Hilleman Jeryl L |
| Relationship: |
Director |
| City: |
Santa Clara |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
108,909 |
|
|
Indirect Shares
|
8,906 |
|
|
| Direct
Value |
$687,981 |
|
|
|
Indirect Value
|
$18 |
|
|
| Total
Shares |
117,815 |
|
|
| Total
Value |
$687,999 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amyris, Inc. |
AMRS |
Chief Financial Officer |
2011-05-20 |
0 |
2011-05-20 |
8,906 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Director |
2016-07-05 |
0 |
2013-05-16 |
0 |
Premium* |
|
|
Intersect Ent, Inc. |
XENT |
|
2019-05-07 |
43,836 |
2017-01-18 |
0 |
Premium* |
|
|
Novocure Ltd |
NVCR |
Director |
2022-06-10 |
2,537 |
2019-05-22 |
0 |
Premium* |
|
|
Minerva Neurosciences, Inc. |
NERV |
Director |
2019-06-26 |
1,000 |
2019-06-26 |
0 |
Premium* |
|
|
Si-Bone, Inc. |
SIBN |
|
2023-06-09 |
19,511 |
2020-06-16 |
0 |
Premium* |
|
|
Hillevax, Inc. |
HLVX |
Director |
2022-04-28 |
42,025 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
71 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMRS |
Amyris, Inc. |
Chief Financial OfficerOfficer |
• – – |
2010-09-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,445 |
|
- |
|
| HLVX |
Hillevax, Inc. |
Director |
– • – |
2022-04-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
42,025 |
|
- |
|
| NVCR |
Novocure Ltd |
Director |
– • – |
2022-06-10 |
4 |
AS |
$69.61 |
$28,331 |
D/D |
(407) |
2,537 |
0 |
% |
|
| NVCR |
Novocure Ltd |
Director |
– • – |
2021-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
814 |
4,214 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2019-06-26 |
4 |
B |
$5.25 |
$5,250 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| NVCR |
Novocure Ltd |
Director |
– • – |
2021-06-09 |
4 |
D |
$210.01 |
$266,713 |
D/D |
(1,270) |
2,944 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
Chief Financial Officer |
• – – |
2018-01-01 |
4 |
D |
$33.93 |
$70,173 |
D/D |
(2,068) |
12,932 |
0 |
- |
|
| NVCR |
Novocure Ltd |
Director |
– • – |
2020-12-18 |
4 |
AS |
$166.40 |
$416,000 |
D/D |
(2,500) |
3,400 |
0 |
% |
|
| NVCR |
Novocure Ltd |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,541 |
5,900 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Chief Financial Officer |
• – – |
2011-05-18 |
4 |
OE |
$3.93 |
$10,124 |
D/D |
2,576 |
2,576 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Chief Financial Officer |
• – – |
2011-05-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,576 |
0 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Chief Financial Officer |
• – – |
2011-05-18 |
4 |
AS |
$28.00 |
$84,000 |
I/I |
(3,000) |
8,906 |
0 |
- |
|
| NVCR |
Novocure Ltd |
Director |
– • – |
2019-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,359 |
3,359 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
Chief Financial Officer |
• – – |
2019-01-01 |
4 |
D |
$26.57 |
$94,261 |
D/D |
(3,548) |
19,884 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Chief Financial Officer |
• – – |
2011-05-20 |
4 |
AS |
$28.00 |
$100,775 |
I/I |
(3,599) |
8,906 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Chief Financial Officer |
• – – |
2011-05-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,599 |
0 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Chief Financial Officer |
• – – |
2011-05-20 |
4 |
OE |
$3.93 |
$14,144 |
D/D |
3,599 |
3,599 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,848 |
12,645 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2021-06-25 |
4 |
AS |
$33.71 |
$148,324 |
D/D |
(4,400) |
8,245 |
0 |
- |
|
| SIBN |
Si-Bone, Inc. |
|
– • – |
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,866 |
19,511 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2013-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2014-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2015-05-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
20,342 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2016-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
25,342 |
0 |
- |
|
| AMRS |
Amyris, Inc. |
Chief Financial Officer |
• – – |
2011-05-19 |
4 |
AS |
$28.00 |
$179,256 |
I/I |
(6,401) |
8,906 |
0 |
- |
|
71 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
